Hims Review

Hims: a mainstream brand makes GLP-1s feel ordinary

Hims is one of the few telehealth names a lot of people already recognize before they ever think about weight loss, and that familiarity is the whole pitch here. Most GLP-1 providers are small, single-purpose startups you have to vet from scratch. Hims is a publicly traded company (part of Hims & Hers) that has spent years building a polished, app-first intake most patients can navigate without help. For the right person, that ordinariness is exactly the appeal: it's semaglutide access that doesn't feel like you're trusting your prescription to a brand-new pop-up. The trade-off is that 'mainstream' also means the program details are unusually thin in public, so you have to know what you're actually signing up for.

What you actually pay, and the part that's easy to miss

Hims lists compounded semaglutide at $199 a month for the medication, which lands right around the category median of $169. On its own that's a fair, middle-of-the-pack number. But the medication price is not the whole bill. Hims runs its weight-loss program through a separate monthly membership that covers the visit and ongoing clinical support, and that membership is charged on top of the drug. There's an introductory first-month rate on the membership before it settles into its standard monthly fee, so your real first month and your real steady-state cost are both higher than the medication line alone suggests.

The honest read: budget for the membership plus the medication, not just the headline $199. Hims is usually billed on multi-month commitments rather than a true pay-as-you-go month, so look closely at the term length and what happens if you stop early before you check out. If you only compare the per-month drug price to other providers, you'll undercount what Hims costs.

The medication and the pharmacies behind it

The weight-loss offering is compounded semaglutide, the same active ingredient as Wegovy and Ozempic, made to order rather than a sealed brand-name pen. Hims doesn't fill these itself. It routes prescriptions to a small set of dedicated 503A compounding pharmacies that, by their own statements, serve Hims & Hers customers exclusively:

• Apostrophe Pharmacy LLC — a licensed Arizona mail-order pharmacy that fulfills solely for Hims & Hers customers
• XeCare, LLC — a dedicated mail-order pharmacy serving only Hims & Hers customers
• Strive Specialties, Inc. and its affiliates — additional fulfillment for the Hims service
• Red Rock Pharmacy (operated by CD Pharmacy LLC) — another fulfillment partner in the network

All four are 503A compounding pharmacies, which matters for expectations. 503A means traditional, patient-specific compounding — not the larger 503B outsourcing-facility model some rivals use. It's a legitimate, widely used path for compounded GLP-1s, but it's a different regulatory lane than an FDA-approved branded pen, and the formulation is prepared rather than commercially manufactured. If having a sealed, brand-name product specifically matters to you, confirm what Hims will actually ship before you commit. The compounded route is what it advertises for weight loss.

What genuinely sets Hims apart

Two things, really. First is scale and reach: Hims & Hers operates as a brand across all 50 states, with a dedicated pharmacy network built to fulfill at volume. That's a level of infrastructure most GLP-1 startups simply don't have. Second is the integrated experience — intake, prescription, refills, and support all live inside one familiar app most people find genuinely easy to use. You're not stitching together a clinic, a pharmacy, and a coaching app; it's one account.

One important caveat on the 50-state claim: that's the brand's overall footprint. Specific treatments can be limited to certain states, and the GLP-1 weight-loss program may be available in a narrower list than the company as a whole. The platform also isn't accessible in Puerto Rico. Check that your own state is covered for the weight-loss program during intake. Nationwide brand availability doesn't mean it's offered where you live.

Who should choose Hims, and who should skip it

Hims fits you if you want a recognizable, low-friction brand, you're comfortable with compounded semaglutide, and you value a smooth app and a real pharmacy network over rock-bottom pricing. It's a sensible default for someone who wants mainstream GLP-1 access without researching a dozen unknown startups.

Skip it if you're cost-optimizing to the dollar — once you add the membership on top of the medication, leaner pay-as-you-go providers can come out cheaper. Skip it, too, if you specifically want brand-name Wegovy or tirzepatide. The weight-loss program here is compounded semaglutide, not a brand pen or a tirzepatide option, so don't assume those are on the menu. And if you dislike multi-month commitments, the term structure here may not suit you.

Trust, oversight, and where the information is thin

On safety fundamentals, Hims looks solid: prescriptions require a clinical evaluation and the fulfillment pharmacies are named, licensed, and dedicated to the service rather than anonymous — but Hims does have an FDA warning letter on file, covered in the regulatory notice below. As a public company, Hims & Hers also operates under more scrutiny than a typical private startup, which is a meaningful trust signal. You can see how we weigh these factors in our scoring methodology.

The real weakness isn't safety — it's transparency. Hims publishes notably little public detail about the weight-loss program's specifics: exact dosing schedules, the precise state list for the GLP-1 program, and the full membership terms aren't laid out as clearly as some competitors lay out theirs. That's why the fine print deserves a careful read, and why prices and program details here can shift without much notice. Confirm the current medication, the membership cost, your state's eligibility, and the commitment length directly at intake.

Bottom line

Hims is the safe, mainstream choice: a recognizable, well-funded brand offering compounded semaglutide at a fair $199 a month for the medication, backed by a real dedicated-pharmacy network and a genuinely easy app. Just go in clear-eyed — the membership is a separate, stacked cost, the product is compounded rather than brand-name, and the public program details are thinner than average. If you value brand familiarity and a frictionless experience over squeezing out the lowest possible price, Hims earns its place on the shortlist. If you're price-hunting or set on a specific brand-name drug, look harder at what's included before you commit.

For a side-by-side, Eden ($198/month) and HumeCare+ ($199/month) are the most comparable options to weigh against Hims.